WBIO.L vs. INTL.L
WBIO.L (WisdomTree BioRevolution UCITS ETF USD Acc) and INTL.L (WisdomTree Artificial Intelligence UCITS ETF - USD Acc) are both exchange-traded funds - WBIO.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD, while INTL.L is a Technology Equities fund tracking the MSCI World/Information Tech NR USD. Both are passively managed. Over the past 3 years, WBIO.L returned 1.10%/yr vs 30.82%/yr for INTL.L. A 0.60 correlation means they provide meaningful diversification when combined. WBIO.L charges 0.45%/yr vs 0.40%/yr for INTL.L.
Performance
WBIO.L vs. INTL.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WBIO.L achieves a 10.42% return, which is significantly lower than INTL.L's 49.02% return.
WBIO.L
- 1D
- 4.36%
- 1M
- 3.58%
- YTD
- 10.42%
- 6M
- 10.85%
- 1Y
- 51.43%
- 3Y*
- 1.10%
- 5Y*
- —
- 10Y*
- —
INTL.L
- 1D
- -0.72%
- 1M
- 17.90%
- YTD
- 49.02%
- 6M
- 46.71%
- 1Y
- 90.61%
- 3Y*
- 30.82%
- 5Y*
- 17.23%
- 10Y*
- —
WBIO.L vs. INTL.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WBIO.L WisdomTree BioRevolution UCITS ETF USD Acc | 10.42% | 13.58% | -14.08% | -5.86% | -18.74% | -1.39% |
INTL.L WisdomTree Artificial Intelligence UCITS ETF - USD Acc | 49.02% | 14.50% | 13.58% | 48.71% | -35.12% | -0.07% |
Correlation
The correlation between WBIO.L and INTL.L is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since Dec 10, 2021 | 0.60 |
Over the past year, the correlation between WBIO.L and INTL.L has dropped to 0.40 - well below their long-term average of 0.60, suggesting their price drivers have been diverging.
WBIO.L vs. INTL.L - Sectors Allocation Comparison
Sectors
WBIO.L
INTL.L
Healthcare
Basic Materials
-
Consumer Defensive
Communication Services
-
Consumer Cyclical
-
Energy
-
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
WBIO.L
INTL.L
Basic Materials
WBIO.L
INTL.L
-
Consumer Defensive
WBIO.L
INTL.L
Communication Services
WBIO.L
-
INTL.L
Consumer Cyclical
WBIO.L
-
INTL.L
Energy
WBIO.L
-
INTL.L
-
Financial Services
WBIO.L
-
INTL.L
Industrials
WBIO.L
-
INTL.L
Real Estate
WBIO.L
-
INTL.L
-
Technology
WBIO.L
-
INTL.L
Utilities
WBIO.L
-
INTL.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WBIO.L vs. INTL.L — Risk / Return Rank
WBIO.L
INTL.L
WBIO.L vs. INTL.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) and WisdomTree Artificial Intelligence UCITS ETF - USD Acc (INTL.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WBIO.L | INTL.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.80 | ||
| Sortino ratioReturn per unit of downside risk | -1.72 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.56 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | 4.40 | 6.14 | -1.74 |
| Martin ratioReturn relative to average drawdown | 10.38 | 18.98 | -8.60 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WBIO.L | INTL.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.91 | 3.71 | -1.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.67 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.19 | 0.94 | -1.14 |
Drawdowns
WBIO.L vs. INTL.L - Drawdown Comparison
The maximum WBIO.L drawdown since its inception was -51.13%, which is greater than INTL.L's maximum drawdown of -37.71%. Use the drawdown chart below to compare losses from any high point for WBIO.L and INTL.L.
Loading charts...
Drawdown Indicators
| WBIO.L | INTL.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.13% | -37.71% | -13.42% |
Max Drawdown (1Y)Largest decline over 1 year | -11.50% | -15.10% | +3.60% |
Max Drawdown (3Y)Largest decline over 3 years | -39.34% | -33.54% | -5.80% |
Max Drawdown (5Y)Largest decline over 5 years | — | -36.92% | — |
Current DrawdownCurrent decline from peak | -18.76% | -0.88% | -17.88% |
Average DrawdownAverage peak-to-trough decline | -26.35% | -10.99% | -15.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.89% | 4.90% | -0.01% |
Volatility
WBIO.L vs. INTL.L - Volatility Comparison
The current volatility for WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) is 6.84%, while WisdomTree Artificial Intelligence UCITS ETF - USD Acc (INTL.L) has a volatility of 9.37%. This indicates that WBIO.L experiences smaller price fluctuations and is considered to be less risky than INTL.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WBIO.L | INTL.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.84% | 9.37% | -2.53% |
Volatility (6M)Calculated over the trailing 6-month period | 17.06% | 18.48% | -1.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.57% | 24.97% | +1.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.70% | 25.61% | -1.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.70% | 26.28% | -2.58% |
WBIO.L vs. INTL.L - Expense Ratio Comparison
WBIO.L has a 0.45% expense ratio, which is higher than INTL.L's 0.40% expense ratio.
Dividends
WBIO.L vs. INTL.L - Dividend Comparison
Neither WBIO.L nor INTL.L has paid dividends to shareholders.
Frequently Asked Questions
WBIO.L and INTL.L have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, INTL.L is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
INTL.L is cheaper with a 0.40% expense ratio, compared with 0.45% for WBIO.L.
WBIO.L is categorized as Health & Biotech Equities, while INTL.L is Technology Equities. WBIO.L tracks NASDAQ Biotechnology TR USD, while INTL.L tracks MSCI World/Information Tech NR USD. Their fees differ too: 0.45% for WBIO.L and 0.40% for INTL.L.
Find the right allocation for WBIO.L and INTL.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer